Abbott news in 2026: 38 dated events
The latest Abbott event on this page is dated Nov 12, 2026. cardiacrhythmnews.com reported: Abbott gains US FDA approval and CE mark for UltiSynq defibrillation lead.
Public (ABT)Medical Equipment Manufacturing10,000+ employeesabbott.comLinkedIn
Get Abbott's live signals in Claude or ChatGPT, or by API
What changed at Abbott this week? Use Autobound signals for abbott.com.- Dated events
- 38
- Last 90 days
- 19
- Latest
- Nov 12, 2026
Source: Autobound Signal API · 112 signals tracked for Abbott · updated
News · latest 10
Latest Abbott news
Showing 10 of 38 dated events. The Signal API returns all of them.
Get them with one API call- Abbott gains US FDA approval and CE mark for UltiSynq defibrillation leadAbbott announced that it has received US FDA approval and a CE mark for the UltiSynq defibrillation lead.
- Abbott Laboratories stock: Product pipeline gains two updatesAbbott Laboratories introduced its Panbio COVID-19/Flu A&B self-test for Canadian families.
- Abbott partners with experts to share scientific knowledge on nutritional care for children.Abbott's Similac brand collaborated with the Vietnam Pediatric Association to organize the forum 'Proven Nutrition - Confident Choices for Parents.'
- Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy SystemAbbott announced positive 30-day clinical trial results from the TECTONIC IDE study evaluating its investigational SonicForce Coronary Intravascular Lithotripsy System.
- Midday Need to Know: Putin signals Ukraine talks, Abbott cuts outlook & moreAbbott Laboratories reported third-quarter revenue of $13.0 billion.
- Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded companyDaniel Salvadori, chief executive officer
- Abbott’s Cologuard Plus® Receives CE Mark for Colorectal Cancer Screening in EuropeAbbott announced that its Cologuard Plus test has received CE Mark certification under the European Union's In Vitro Diagnostic Regulation.
- Abbott's Cologuard Plus® Receives CE Mark for Colorectal Cancer Screening in EuropeAbbott plans to introduce its non-invasive colorectal cancer screening test Cologuard Plus in selected European markets following CE mark receipt.
- Abbott CardioMEMS Wins FDA Approval for Patient-Facing App FeaturesAbbott plans to make its CardioGuide HF App and a companion software feature, Dynamic Treatment Plan, available later this year.
- Continuous glucose monitoring is associated with lower mortality in type 2 diabetes with basal insulinAbbott has developed Libre Assist, a new AI-powered feature for its application that estimates how certain foods may affect glucose levels, though it is not yet available in Spain.
Showing 10 of 38 dated events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Abbott with the Signal API
One POST /v1/companies/enrich call with abbott.com returns Abbott news signals (news), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbott.com","signal_types":["news"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.
Same industry
News at related companies
Questions about Abbott news
What is the latest news on Abbott?
What is going on with Abbott?
Page updated , the date of the newest row on this page.
Source. News articles about the company, one source link per event.
Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.
Data as of .